The influence of acute smoking on leucocytes, platelets and the endothelium

Atherosclerosis

Volumn 141, Issue 1, 1998, Pages 133-139

  Blann, Andrew D ^a   Kirkpatrick, Ursula ^b   Devine, Carol ^b   Naser, Salina ^b   McCollum, Charles N ^b  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Leucocytes; Neutrophils; Platelets; Smoking; Von Willebrand factor

Indexed keywords

CIGARETTE SMOKE; ELASTASE; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; ATHEROSCLEROSIS; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM LESION; FEMALE; HUMAN; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; NEUTROPHIL; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE; THROMBOSIS;

ADULT; BLOOD PLATELETS; ENDOTHELIUM, VASCULAR; FEMALE; FIBRINOGEN; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTE COUNT; LEUKOCYTE ELASTASE; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; P-SELECTIN; PLATELET ACTIVATION; PLATELET COUNT; SMOKING; VON WILLEBRAND FACTOR;

EID: 0032487565     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00163-4     Document Type: Article

References (44)

1. Bartecchi C.E., MacKenzie T.D., Schrier R.W. The human cost of tobacco use. New. Engl. J. Med. 330:1994;907.
2. Doll R., Peto R., Wheatley K., Gray R., Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. Br. Med. J. 309:1994;901.
3. Krupski W.C. The peripheral vascular consequences of smoking. Ann. Vasc. Surg. 5:1991;91.
4. Zalokar J.B., Richard J.L., Claud J.R. Leukocyte count, smoking and myocardial infarction. New. Engl. J. Med. 304:1981;465.
5. Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting and the risk of ischaemic heart disease. Lancet 1987;ii:986.
6. Allen R.A., Kluft C., Brommer E.J.P. Effect of chronic smoking on fibrinolysis. Arteriosclerosis. 5:1985;443.
7. Belch J.J.F., McArdle B.M., Burns P., Lowe G.D.O., Forbes C.D. The effects of acute smoking on platelet behaviour, fibrinolysis and haemorheology in habitual smokers. Thromb. Haemost. 51:1984;6.
8. Blann A.D., McCollum C.N. Adverse influence of cigarette smoking on the endothelium. Thromb. Haemost. 70:1993;707.
9. Schwartz J., Weiss S.T. Cigarette smoking and peripheral blood leukocyte differentials. Ann. Epidemiol. 4:1994;236.
10. Yarnell J.W.G., Sweetnam P.M., Rogers S. et al. Some long term effects of smoking on the haemostatic system: a report from the Caerphilly and Speedwell Collaborative surveys. J. Clin. Pathol. 40:1987;909.
11. MacNee W., Wiggs B., Belzberg A.S., Hogg J.C. The effect of cigarette smoking on neutrophil kinetics in human lungs. New. Engl. J. Med. 321:1989;924.
12. Chignard M., Balloy V., Renesto P. Leukocyte elastase mediated release of von Willebrand factor from cultured endothelial cells. Eur. Respir. J. 6:1993;423.
13. Blann A.D., Seigneur M., Adams R., McCollum C.N. Neutrophil elastase, von Willebrand factor, soluble thrombomodulin and percutaneous oxygen in peripheral atherosclerosis. Eur. J. Vasc. Endovasc. Surg. 12:1996;218.
14. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801.
15. Blann A.D., Tabener D.A. A reliable marker of endothelial cell function. Does it exist? Br. J. Haematol. 90:1995;244.
16. Nowak J., Murray J.J., Oates J.A., Fitzgerald G.A. Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation. 76:1987;6.
17. Noronha-Dutra A.A., Epperlein M.M., Woolf N. Effect of cigarette smoking on cultured human endothelial cells. Cardiovasc. Res. 27:1993;774.
18. Celermajer D.S., Sorensen K.E., Georgakopoulos D., Bull C., Thomas O., Robinson J., Deanfield J.E. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 88:1993;2149.
19. Davis J.W., Shelton L., Eigenberg D.A., Hignite C.E., Watanabe I.S. Effects of tobacco and non-tobacco cigarette smoking on endothelium and platelets. Clin. Pharmacol. Ther. 37:1985;529.
20. Blache D., Bouthillier D., Davignon J. Acute influence of smoking on platelet behaviour, endothelium and plasma lipids and normalisation by aspirin. Atherosclerosis. 93:1992;179.
21. Wennmalm A., Benthin G., Granstrom E.F., Persson L., Petersson A.S., Winell S. Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolises in young men. Circulation. 83:1991;1698.
22. Mustard J.F., Murphy E.A. Effect of smoking on blood coagulation and platelet survival in man. Br. Med. J. 1:1963;846.
23. Blann A.D., Lip G.Y.H. Hypothesis: is soluble P-selectin a new marker of platelet activation. Atherosclerosis. 128:1997;135.
24. Blann A.D., Steele C., McCollum C.N. The influence of smoking on soluble adhesion molecules and endothelial cell markers. Thromb. Res. 85:1997;433.
25. Ridker P.M., Hennekens C.H., Roitman-Johnson B., Stempfer M.J., Allen J. Plasma concentrations of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet. 351:1998;88.
26. Koundouros E., Odell E., Coward P., Wilson R., Palmer R.M. Soluble adhesion molecules in serum of smokers and non-smokers, with and without periodontitis. J. Periodont. Res. 31:1996;596.
27. Bass D.A., Parce J.W., Dechatelet L.R., Szejda P., Seeds M.C., Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J. Immunol. 130:1983;1910.
28. Suttorp N., Nolte A., Wilke A., Drenckhahn D. Human neutrophil elastase increases the permeability of cultured pulmonary endothelial cell monolayers. Int. J. Microcirc. Clin. Exp. 13:1993;187.
29. Blann A.D., Davis A., Miller J.P., McCollum C.N. von Willebrand factor and soluble E selectin in hyperlipidaemia: relationship to lipids and vascular disease. Am. J. Hematol. 55:1997;15.
30. Yamazaki M., Asakura H., Saito M. et al. Relationship between elevation in the plasma concentration of elastase-α 1 proteinase inhibitor complex (E-α 1 PI) and haemostatic parameters during haemodialysis. Blood. Coag. Fibrinolysis. 6:1995;5.
31. Bzeizi K.I., Jalan R., MacGregor I., Drummond O., Lee A., Hayes P.C. Neutrophil elastase: a determinant of endothelial damage and reperfusion injury after liver transplantation. Transplantation. 62:1996;916.
32. Gando S., Nakanishi Y., Kameue T., Nanzaki S. Soluble thrombomodulin increases in patients with disseminated intravascular coagulation and in those with multiple organ dysfunction after trauma: role of neutrophil elastase. J. Trauma. 39:1995;660.
33. Smith F.B., Lee A.J., Fowkes F.G.R., Rumley A., Lowe G.D.O. Smoking, haemostatic factors and the severity of aorto-iliac and femoro-popliteal disease. Thromb. Haemost. 75:1996;19.
34. Kalra J., Chaudhary A.K., Prasad K. Increased production of oxygen free radical in cigarette smokers. Int. J. Exp. Pathol. 71:1991;1.
35. 2-isoprostanes) in smokers. New. Engl. J. Med. 332:1995;1198.
36. Fijnheer R., Frijns C.J.M., Korteweg J., Rommes H., Peters J.H., Sixma J.J., Nieuwenhuis H.K. The origin of P-selectin as a circulating plasma protein. Thromb. Haemost. 77:1997;1081.
37. Wu K.K. Platelet activation mechanisms and markers in arterial thrombosis. J. Int. Med. 239:1996;17.
38. Roth G.M., McDonald J., Sheard C. The effect of smoking cigarettes and of intravenous administration of nicotine on the electrocardiogram, basal metabolic rate, cutaneous temperature, blood pressure and pulse rate of normal persons. J. Am. Med. Assoc. 125:1944;761.
39. Kloczko J., Wojtukiewicz M.Z., Bielawiec M., Galar M., Tarasow E. von Willebrand factor antigen and fibronectin in essential hypertension. Thromb. Res. 79:1995;331.
40. Blann A.D., Naqvi T., Waite M., McCollum C.N. von Willebrand factor and endothelial damage in essential hypertension. J. Human. Hypertens. 7:1992;107.
41. Verhaar M.C., Beutler J.J., Gaillard C.A., Koomans H.A., Fijnheer R., Rabelink T.J. Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin. J. Hypertens. 16:1998;45.
42. Lip G.Y.H., Blann A.D., Zarifis J., Beevers M., Lip P.L., Beevers D.G. Soluble adhesion molecule P-selectin and endothelial cell dysfunction in essential hypertension: implications for atherogenesis? A preliminary report. J. Hypertens. 13:1995;1674.
43. Lowe D.G.O., Wood D.A., Douglas J.T. et al. Relationship of plasma viscosity, coagulation and fibrinolysis to coronary risk factors and angina. Thromb. Haemost. 65:1991;339.
44. Altman D.G. Practical statistics for medical research. 1991;455 Chapman and Hall, London.